GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
1.3k
c/tirzepatide·posted 2 months ago by u/cato_girard

how much of what we believe about Mounjaro actually comes from Zepbound threads

Side Effects Well Actually ×2 Sourced ×3

Asking properly rather than in a comment on somebody else’s thread: how much of what we believe about Mounjaro actually comes from Zepbound threads.

On comparing yourself with the trial number.

SURMOUNT-1 reported roughly 21% mean body weight change at 72 weeks on the highest arm. Three things get dropped every time that figure is quoted here. It is a mean, and the distribution around it is very wide. It is 72 weeks, which is a year and a half. And it is a trial population with trial support, which is not the same as a person with a spreadsheet.

Use it as a rough shape, not a benchmark. A 12% year is inside the ordinary range and people quit over it every week on this board.

Research-use-only material is not approved for human use. Anything in this thread about how a research vial "should" titrate is a discussion about chemistry, not a plan.

Vials and pens carry the same molecule; what differs is fill volume, device tolerance and whether you are doing your own arithmetic. Neither is inherently more accurate.

Happy to answer the boring questions. Those are usually the ones worth asking.

1,484 up / 217 down87% upvoted40 commentsid 1s31e811 May 2026

40 comments

22 in this archive, depth 5

best — the order this archive was captured in

u/neha_falk171 points·2 months ago

The distribution matters more than the mean. In the trial population the interquartile spread was wide enough that two honest people can have completely different runs on the same arm.

replysharereportpermalink
u/samir_falk135 points·2 months ago

Went 10 to 12.5 on the calendar and had the worst fortnight of the whole run. Dropped back to 10 and everything settled.

replysharereportpermalink
u/line_petrov74 points·2 months ago

The four-week interval in the label is a minimum. Nothing about the pharmacology requires you to step on schedule, and the trials stepped on a calendar because trials have to.

replysharereportpermalink
[removed]51 points·2 months ago

[removed by moderator]

replysharereportpermalink
u/cato_girardOP41 points·2 months ago

the trials titrated on a calendar, real people titrate on symptoms

replysharereportpermalink
u/search_before_post93 points·2 months ago

the appetite effect is blunter than sema, in a good way, most weeks

replysharereportpermalink
u/cato_girardOP43 points·2 months ago

What step are you on and how long have you been there?

replysharereportpermalink
u/cato_girardOP17 points·2 months ago

Correction to my own post above — I said 15mg and I have been on 2.5mg since the spring. Same argument, wrong number.

replysharereportpermalink
u/neha_falk11 points·2 months ago

Disagree with the conversion table. There is no validated equivalence between the two molecules and posting one as though there is does real damage.

replysharereportpermalink
u/nordic_pricing14 points·2 months ago

zepbound and mounjaro are the same compound with different labels

replysharereportpermalink
u/hub_opssite staff45 points·2 months ago

switching from sema is not a dose conversion, there is no clean equivalence

replysharereportpermalink
u/zeynep_ndiaye25 points·2 months ago

pens and vials are the same molecule, the price is the difference

replysharereportpermalink
u/nz_unfunded78 points·2 months ago

Same experience with the appetite effect being flatter across the week rather than front-loaded.

replysharereportpermalink
u/sanne_novak64 points·2 months ago

It is a dual GIP and GLP-1 receptor agonist, and the GIP arm is the part that has no equivalent in the semaglutide threads. That is why the side-effect profile reads differently rather than just milder.

replysharereportpermalink
u/hair_shed_hannah107 points·2 months ago

Switching from semaglutide, since three people asked in this thread alone.

There is no published dose equivalence between the two. The conversion tables that circulate are somebody’s arithmetic, not data. What people report here is that the first month after a switch is often flat, that the appetite effect feels differently shaped rather than simply stronger, and that starting at the bottom of the ladder again is the common approach.

None of that is a recommendation. It is what the threads say, and the threads are not a clinic.

replysharereportpermalink
u/ferritin_low56 points·2 months ago

Weekly dosing again, half-life in the same neighbourhood as sema, so a step change takes about a month to reach steady state. Judging a new step at day five is judging noise.

replysharereportpermalink
u/titration_marshalMOD42 points·2 months ago

Removed the conversion table. There is no published equivalence between the two molecules and posting one as fact is exactly the kind of thing that gets copied for years.

replysharereportpermalink
u/zaid_balogun35 points·2 months ago

2.5mg is a four-week starting dose, not a maintenance dose. Worth being precise since people search these threads.

replysharereportpermalink
u/zeynep_zielinski32 points·2 months ago

SURMOUNT-1 ran 72 weeks with the top arm around 21% mean body weight change. SURPASS is the diabetes programme and reports glycaemic endpoints, so quoting the two interchangeably is a category error.

replysharereportpermalink
u/santiago_villalobos18 points·2 months ago

Sulphur burps for the first eight days after each step, then nothing. Predictable enough that I planned my week around it.

replysharereportpermalink
u/bastian_eriksen13 points·2 months ago

That percentage is body weight change, not body fat. Different measurement, and the distinction gets lost every time.

replysharereportpermalink
u/kofi_balogun4 points·2 months ago

Agreed, and the trial number is a mean of a very wide distribution — the tails are enormous and nobody posts from the middle.

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/tirzepatide

Tirzepatide-specific discussion: the dual-agonist pharmacology, the 2.5 → 15mg ladder, the appetite profile people describe as different from semaglutide, and the SURMOUNT/SURPASS trial programme. Comparisons with semaglutide are welcome as long as they are specific about dose equivalence being unknown.

187kmembers
130submissions
Aug 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/tirzepatide rules
  1. "Tirz is better than sema" needs a comparator dose or it is a vibe, not a claim.
  2. Vial-splitting and self-compounding discussion stays in c/reconstitution.
  3. No pen-cracking tutorials. Discussing that people do it is fine; instructions are not.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.